Global Acne Therapeutics Market Forecasts to 2024 – Allergan, Valeant Pharmaceutical International, Bayer, and Galderma are Dominating – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Acne
Therapeutics Market- Growth, Trends, and Forecast (2019 – 2024)”
report has been added to ResearchAndMarkets.com’s
offering.

The acne therapeutics market is expected to register a CAGR of nearly
4.23% during the forecast period, 2019-2024.

The key factors propelling the growth of the acne therapeutics market
are increasing sedentary lifestyles and unhealthy lifestyles, the rise
in disposable income of consumers, increasing awareness about upcoming
trends in acne treatments, and high prevalence of acne, globally.

The diet and nutrient intake determine the overall health of an
individual. The food that is high in refined carbohydrates increases
insulin, which results in hormonal problems, promoting acne formation.

More than 90% of the world’s population is found to be affected by acne
at some point in their life. In the United States, there are 60 million
suffering from acne problems. This includes all grades of acne, from the
mild, occasional breakout to more severe conditions. Of the 60 million,
20% have some form of acne bad enough that it results in scarring of the
skin. Therefore, there is an increasing adoption of acne cure products,
which helps in driving the overall market.

In addition, rapid economic growth has also led to a substantial
increase in the disposable incomes of middle-class people. With this
increasing income, people are ready to spend more on their facial looks.
Thus, the market for acne therapeutics is projected to grow rapidly over
the forecast period.

Key Market Trends

Topical is the Segment Under Administration that is Expected to Grow
the Fastest

The utilization rate of topical medications for acne treatment is high,
owing to the high availability of these acne products, with a high
success rate and lesser side effects. These agents are directly applied
on the skin and need to be used continuously for longer periods of time,
from several weeks to months, to get effective result.

Therefore, the preference for topical treatment is more, as compared to
the oral mode of therapeutic administration. These oral medications are
recommended as systemic therapies, after topical treatments fail to
evoke a response.

Asia-Pacific Holds the Fastest Growth and is Expected to follow the
Same Trend over the Forecast Period

Asiaand Pacific is expected to be the fastest-growing region, due to
increasing sedentary lifestyles and unhealthy food habits. Prosperity
and a faster pace of life have changed the Chinese eating habits.

Eating too much with high amounts of fat and calories and exercising
less have led to an increase in obesity and acne problems. However,
Asia-Pacific is expected to register the highest CAGR, due to the
increase in affordability, surge in healthcare expenditure, and rise in
awareness about safe acne medication products.

Competitive Landscape

There are many players in the market coming up with new products for
acne treatment. Allergan, Valeant Pharmaceutical International, Bayer,
and Galderma (Nestle Skin Health) are some of the major players in the
acne therapeutics market.

Topics Covered

1 Introduction

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Dynamics

4.1 Market Overview

4.2 Market Drivers

4.2.1 Increasing Sedentary Lifestyle and Unhealthy Food Habits

4.2.2 Rise in Disposable Income of Consumers

4.2.3 Increasing Awareness About Current and Upcoming Acne Treatments

4.2.4 High Global Acne Prevalence

4.3 Market Restraints

4.3.1 Safety Issues Regarding the Products

4.3.2 Entry of Generics in the Acne Treatment Drug Market

4.4 Porter’s Five Forces Analysis

5 Market Segmentation

5.1 By Treatment

5.1.1 Therapeutics

5.1.1.1 Retinoid

5.1.1.2 Antibiotics

5.1.1.3 Hormonal Agents, Combination Medications, Anti-inflammatory

5.1.1.4 Other Agents

5.1.2 Other Treatments

5.2 By Route of Administration

5.2.1 Oral

5.2.2 Topical

5.3 Geography

5.3.1 North America

5.3.2 Europe

5.3.3 Asia-Pacific

5.3.4 Middle East & Africa

5.3.5 South America

6 Competitive Landscape

6.1 Company Profiles

6.1.1 Cipher Pharmaceuticals

6.1.2 GlaxoSmithKline

6.1.3 Bayer AG

6.1.4 Teva Pharmaceuticals

6.1.5 Ranbaxy

6.1.6 Allergan

6.1.7 F. Hoffmann-la Roche Ltd.

6.1.8 Nestle S.A. (Galderma)

6.1.9 Johnson & Johnson

6.1.10 Valeant Pharmaceuticals International Inc.

7 Market Opportunities and Future Trends

For more information about this report visit https://www.researchandmarkets.com/research/876nxn/global_acne?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Acne
Drugs